No Data
Emerging markets stocks digest: Fulta continues to rise significantly, sea U sea hits the daily limit.
<4598> DELTA-P 533 +47 surged significantly. After the trading on the 28th, the progress of the phase 1/2 clinical trial of DFP-10917 and VEN was announced, which is considered a positive development. DFP-10917, when given as a low-dose continuous infusion, is believed to be highly safe, stops cancer cells in the G2/M phase, and induces apoptosis (programmed cell death). Therefore, a strong synergistic effect can be expected when combined with VEN (a BCL-2 inhibitor). Currently, a phase 1 clinical trial is underway.
TOKYO - The newly launched regional revitalization project in collaboration with Shogakukan Corocoro Comic editorial department is showing a decline.
Decline announced. It was announced that a new regional revitalization project in collaboration with Shogakukan CoroCoro Comic editorial department has started. As the first project, a collaboration with CoroCoro Comic characters will be implemented in the "Mystery Solving Gaming" at the 'INTERNATIONAL SDGs FES in EDOGAWA 2024 supported by TGC'. In regional revitalization projects conducted by the company in various regions, there will be future joint IP development in the Web3 field.
W Tokyo: Interim report
W Tokyo: Financial Report - Term 9 (2023/07/01 - 2024/06/30)
Volume change rate ranking (9 o'clock) - Toki Yoshio, broadcasting link, etc. ranked in.
*In the volume change rate ranking, you can see the interest of market participants such as the trend of searching by comparing the average volume over the past 5 days with the volume on the delivery day. *Top volume change rate [August 30 9:32 current] (Comparison of average volume over the past 5 days) Security code Security name Volume 5-day average volume Volume change rate Stock price change rate <4579> Rakuroria 493,200 107,185.08 208.69% 0.093
W Tokyo: FY2024 Financial Results Presentation Material for the Year Ending June.
No Data
No Data